Click to deselect and select. Nov 13, 2025, 12:54 AM IST AvanceTechnologies - Un-Audited Financial Results For The Quarter And Half Year Ended As On 30Th September, 2025. Nov 13, 2025, 12:45 AM IST ...

remove-circle Internet Archive's in-browser bookreader "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The 75,000-square-foot building ...

ALACHUA, Fla. and TAMPA, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (AXGN), a global leader in developing and marketing innovative surgical technologies for the restoration of peripheral ...

The U.S. FDA granted accelerated approval for the Biologics License Application for Axogen Inc.'s Avance, an acellular nerve allograft that serves as a scaffold for nerve regrowth, for treatment of ...

Dec 3 (Reuters) - The U.S. Food and Drug Administration has approved Axogen's (AXGN.O), opens new tab nerve repair graft, the health regulator said on Wednesday, paving the way for 12 years of ...

Nov 13, 2025, 12:54 AM IST AvanceTechnologies - Un-Audited Financial Results For The Quarter And Half Year Ended As On 30Th September, 2025. Nov 13, 2025, 12:45 AM IST AvanceTechnologies - Board ...

AxoGen ((AXGN)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help ...

Barchemy founder and CEO Larry Toscano will retain a significant ownership stake and continue to lead the company Barchemy was founded in 2015 Avance Investment Management has made an investment in ...

Avance Technologies share price has delivered multibagger returns of 3,260% in five years.(Image: Pexel) Avance Technologies share price was locked in at 2% upper circuit of ₹1.68 apiece on the BSE ...

Avance Technologies share price hit upper circuit for the fifth straight trading session to touch a 52-week high on Monday amid heavy buying volumes. The small-cap penny stock gained as much as 2% to ...